P49137 (MAPK2_HUMAN) Homo sapiens (Human)

MAP kinase-activated protein kinase 2 UniProtKBInterProSTRINGInteractive Modelling

400 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

30 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Ternary complex of P38 and MK2 with a P38 inhibitor
4tyh
 Heteromer
P47811; 		51-400
1×39G;
Assess
Phosphorylated p38 and MAPKAPK2 complex with inhibitor
6tca
 Heteromer
Q16539; 		51-399
1×39G;
Assess
Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer
2onl
 Heteromer
Q16539; 		46-393
Assess
Structure of p38alpha complex
2oza
 Heteromer
P47811; 		51-390
Assess
Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer
2okr
 Heteromer
Q16539; 		370-393
Assess
Binding site mapping of protein ligands
3gok
homo-12-mer46-350
12×P4O;
Assess
Crystal structure of MAPKAP Kinase-2 (MK2) in complex with non-selective inhibitor
3wi6
homo-12-mer46-347
12×YRZ;
Assess
Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)
3a2c
homo-12-mer47-345
24×PDY; 1×SO4;
Assess
Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperaz…
6t8x
homo-6-mer44-331
6×B97; 6×CL; 6×MW8;
Assess
Re-refinement of MAPKAP kinase-2/inhibitor complex 3fyj
7nry
homo-3-mer45-366
3×B97; 3×CL; 3×MLA;
Assess
Crystal structure of a benzthiophene lead bound to MAPKAP Kinase-2 (MK-2)
3fyk
homo-3-mer45-364
3×B98;
Assess
Crystal structure of an optimzied benzothiophene inhibitor bound to MAPKAP Kinase-2 (MK-2)
3fyj
homo-3-mer45-364
3×B97;
Assess
MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine
3kc3
homo-3-mer43-350
3×MK2;
Assess
Crystal Structure of MAPKAP2
1kwp
monomer46-385
7×HG;
Assess
Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2
2p3g
monomer45-364
1×F10;
Assess
Crystal structure of MAPKAK kinase 2 (MK2) complexed with a spiroazetidine-tetracyclic ATP site inh…
3m2w
monomer47-364
1×L8I; 1×MG;
Assess
Crystal structure of MAPKAP kinase 2 (MK2) complexed with a potent 3-aminopyrazole ATP site inhibit…
3kga
monomer47-364
1×MG; 1×LX9;
Assess
The Crystal Structure of MAPKAP kinase 2 domain from Biortus
8xx1
monomer47-364
Assess
Crystal structure of MAPKAP kinase 2 (MK2) complexed with a tetracyclic ATP site inhibitor
3m42
monomer47-364
1×MG; 1×HGF;
Assess
MK2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-N-methylbenzo[b]thiop…
3ka0
monomer47-364
1×MK3;
Assess
Structure of MK2 Complexed with Compound 76
2pzy
monomer42-346
1×B18;
Assess
Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)
2jbp
monomer46-350
1×P4O;
Assess
The Crystal Structure of MAPK2 from Biortus.
8xu4
monomer47-351
Assess
Crystal structure of staurosporine bound to MAP KAP kinase 2
1nxk
monomer42-345
1×STU;
Assess
Protein kinase MK2 in complex with an inhibitor (crystal form-1, soaking)
2jbo
monomer44-347
1×PO4; 1×P4O;
Assess
Crystal Structure of a Squarate Inhibitor bound to MAPKAP Kinase-2
3fpm
monomer44-345
1×793;
Assess
MK2 kinase bound to Compound 1
3r2y
monomer46-345
2×MLI; 1×P4O;
Assess
Crystal structure of ADP bound to MAP KAP kinase 2
1ny3
monomer46-345
1×ADP;
Assess
MK2 kinase bound to Compound 2
3r30
monomer46-345
1×CD2;
Assess
MK2 kinase bound to Compound 5b
3r2b
monomer47-345
1×05B;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1nxk.1.Amonomer0.7942-345
1×STU;100.00
Assess
1kwp.2.Amonomer0.6944-378
4×HG;100.00
Assess
2onl.1.Bmonomer0.6646-393
100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21nxk.1.Amonomer0.7942-345
1×STU;99.72
Assess